What Hidden Infections and Toxins Contribute to Chronic Inflammation in Breast Implant Illness Patients?
(Based on a recent interview with Dr. Mark Su discussing chronic Lyme disease, mold illness, parasitic infections, and environmental toxins as drivers of chronic inflammation - https://www.youtube.com/watch?v=rlzDhIEXlwE)
When patients come to Dr. Robert Whitfield with symptoms they associate with breast implant illness (BII), the conversation rarely stays limited to the implant itself. Many of these patients are also carrying an unrecognized burden of chronic inflammation from sources that have nothing to do with their surgery: tick-borne illness, mold exposure, parasitic infections, and everyday environmental toxins.
In a recent podcast conversation, Dr. Whitfield sat down with Dr. Mark Su, a functional and integrative medicine physician who practices through Rootseek.com, to unpack how these hidden drivers of chronic inflammation in breast implant illness patients complicate both diagnosis and recovery.
As Dr. Whitfield explained during the conversation, breast implant illness is best understood as "a chronic inflammatory process of which a medical device, in this case a breast implant, plays a role. It's not the only thing contributing to chronic inflammation in our patients." That framing set the stage for a wide-ranging discussion about the other contributors clinicians often overlook.
How Do People Actually Get Chronic Lyme Disease?
According to Dr. Su, one of the biggest sources of confusion is that "Lyme disease" is used as a loose catch-all term. Before he even discusses testing with a patient or practitioner, he wants to know what they actually mean: the specific bacteria Borrelia burgdorferi, the broader class of Borrelia species, or the wider group of "co-infections," which can include Bartonella, Babesia, Ehrlichia, Anaplasma, and even certain parasites and viruses that travel alongside tick exposure.
History-taking is complicated by the fact that most people never notice the bite that caused their infection. Ticks, especially in their nymph stage, can attach for days without being felt, and patients often describe mistaking an early attached tick for a piece of dirt or a speck of dust.
Dr. Su also pointed to a less familiar possibility: there is scientific rationale supporting the idea that Lyme disease may, in some cases, be transmitted in utero from a mother who was carrying the infection. This means a patient's history might not include any known tick exposure at all.
The common assumption that deer are the primary source of exposure is also worth revisiting. Dr. Su noted that mice living inside homes may represent a greater practical exposure risk than deer in the woods, particularly because pets bring ticks indoors, where they can detach and go unnoticed in living spaces.
Why Lyme Disease Testing Is So Complicated
Antibody Testing: The Most Common Approach
Most Lyme disease labs, including widely used options such as Vibrant, rely on antibody testing that looks at IgG and IgM markers. A positive result reflects that the immune system has responded to exposure at some point, which is not always the same as confirming an active infection right now.
This gets more complicated with IgM antibodies specifically. In most infections, IgM antibodies are expected to fade within roughly six weeks of new exposure. Borrelia bacteria, however, can generate recurrent IgM positivity for reasons tied to the bacteria's own biology, which means a positive IgM result does not always mean recent exposure.
ELISpot and PCR Methodology
Some specialized labs use ELISpot testing, which looks directly at markers on T lymphocytes rather than antibodies, offering a different kind of signal. Other labs use PCR testing, the same general methodology familiar from COVID-19 testing, which looks for genetic material from the pathogen itself. A positive PCR result raises its own question: is the genetic material coming from a live organism, or is it a remnant of something no longer active?
Dr. Whitfield noted that this same PCR methodology has proven valuable in his own research, in a different context. His published research (Whitfield et al., Microorganisms 2024) analyzed capsule tissue removed from around breast implants and found bacterial contamination in 29 percent of tested samples, findings that went undetected using standard culture methods. This is currently the largest PCR-tested explant capsule series in the world, and it illustrates why PCR-based approaches are gaining attention across different areas of chronic inflammation research.
Dr. Whitfield also referenced a separate line of research: a group in Denmark published findings suggesting that when scar tissue around breast implants becomes firmer over time, it may reflect an upregulated immune response involving T-cells, B-cells, and plasma cells, similar to patterns associated with organ rejection, measured by analyzing RNA activity in the surrounding tissue. This remains an evolving area of research rather than a settled explanation, but it points to the same theme running through the conversation: inflammation around implants, and in the body more broadly, often involves more than one contributing factor.
For patients, the practical takeaway is that no single lab result tells the whole story. According to Dr. Su, correlating symptoms with test findings is "a whole art" that requires a practitioner comfortable holding some uncertainty while still building a rational, defensible picture for each patient.
Mold Illness: A Different Kind of Complexity
Dr. Su described mold illness as, in some ways, more challenging to sort through than Lyme disease, largely because the inflammation it causes can come from two different directions at once. Fungus or yeast can be present and active inside the body, generating its own inflammatory response, while separately, ongoing exposure to mold in a home or workplace can generate inflammation from the outside in. Some patients are dealing with both at the same time.
A detailed history matters here too. Any past water damage, flooding, or visible mold at a home or workplace, even years earlier, is relevant information. From a testing standpoint, Dr. Su's practice typically starts with a provocative challenge using glutathione, followed by mycotoxin testing, along with a broader look at a patient's detoxification pathways, since genetic differences in how people process and clear toxins can meaningfully affect the picture.
Both physicians were clear about avoiding catastrophizing. Dr. Su described a pattern within the mold illness community where a single test finding can push a patient toward drastic, expensive decisions before more measured steps have been tried. His starting recommendation instead is almost always to improve air quality first, particularly in bedrooms and bathrooms, since these spaces are frequently where hidden mold problems live. For many patients, this step alone is enough to meaningfully improve how they feel, even when the underlying source in the home is never fully identified.
Patients interested in getting a broader read on their own mycotoxin and toxin exposure alongside their clinical history can start with the Total Tox Burden Test, which is designed to support this kind of conversation with a qualified provider.
Parasitic Infections: An Underappreciated Piece of the Puzzle
Parasitic infections receive very little attention in conventional medical training, yet Dr. Su described them as one of the more overlooked contributors to unexplained symptoms, especially for patients with a history of international travel. In his Austin-based practice, this pattern shows up frequently in patients who traveled to Mexico and ate food off the resort property. Dr. Su considers that history alone a strong enough marker to raise suspicion of a parasitic infection, especially when it is paired with a remembered episode of travel-related illness that was never treated.
Diagnosis is genuinely difficult. Standard stool testing is often insufficient because many parasites are not consistently present in stool at any given time, which means a negative result does not rule out an infection. A small number of specialized labs outside the conventional insurance-covered system offer more targeted testing, and some practitioners also look indirectly at supporting evidence, such as certain CBC findings or immune patterns associated with TH2-skewed reactivity.
Dr. Whitfield noted that Entamoeba histolytica remains one of the most common parasites worldwide and a well-documented cause of liver abscesses, a point that underscores why clean water access and food safety while traveling matter as much as they do.
Environmental Toxins and the Cumulative Burden
Beyond Lyme disease, mold, and parasites, Dr. Su and Dr. Whitfield also discussed environmental toxins that show up in patients without any obvious explanation. These include glyphosate exposure connected to agricultural work or living near farmland, atrazine exposure linked to living near golf courses (an exposure that has also drawn mainstream attention for its association with Parkinson's disease), microplastics, and heavy metals such as arsenic, lead, and cadmium that continue to appear in food and water testing across the country.
Rather than addressing each chemical individually, Dr. Su explained that his practice tends to treat these exposures as a category, since the interventions used tend to overlap regardless of which specific compound shows up on a lab panel. Both physicians emphasized that awareness of these exposures should not tip into feeling overwhelmed. As Dr. Su put it, "slow progress is better than no progress." Practical, incremental steps, such as filtering drinking water or improving indoor air quality, can meaningfully reduce a patient's overall exposure burden without requiring a complete lifestyle overhaul.
Establishing a baseline understanding of where a patient's inflammation stands is often the first data point used to decide whether a deeper workup, for Lyme, mold, or toxin exposure, is worth pursuing. The Inflammation Test is designed to support exactly this kind of starting conversation with a provider.
How These Hidden Drivers Connect to Chronic Inflammation in Breast Implant Illness Patients
Dr. Whitfield noted that roughly 2.2 million breast implants are placed worldwide each year. For the subset of those patients who go on to report BII-associated symptoms, the surrounding chronic inflammatory response reflects more than the presence of a device alone. How a person has managed exposure to Lyme disease, mold, parasites, and environmental toxins, combined with their own capacity to process and clear these burdens, along with stress and other lifestyle inputs, all factor into how the body responds over time.
As Dr. Whitfield put it during the conversation, patients are "a collection of experiences," and each of those experiences may be contributing to the same underlying inflammatory picture. This is why a comprehensive evaluation, one that looks well beyond the implant itself, is central to how Dr. Whitfield approaches BII-related care. Addressing Lyme, mold, or toxin exposure alongside surgical planning does not guarantee a particular outcome, but for many patients it is a meaningful part of building a fuller picture before making decisions about explant surgery or other treatment.
How the SHARP Framework Applies to This Discussion
SHARP, which stands for Strategic Holistic Accelerated Recovery Program, reflects the same principle running through this entire conversation: chronic inflammation in breast implant illness patients rarely traces back to a single cause, so a thorough evaluation should look at the whole picture, both before and after surgery.
Preparation before surgery is a core piece of this. Identifying and addressing sources of chronic inflammation, whether that is Lyme disease, mold exposure, parasites, or toxin burden, ahead of an operative procedure may help support a smoother recovery process. Immune support and toxicity identification go hand in hand with this preparation, since understanding a patient's testing history, whether that involves antibody panels, PCR testing, mycotoxin testing, or toxin panels, helps build a clearer, more individualized picture of what may be contributing to symptoms.
Gut health and hormonal balance are also part of this broader picture. Parasitic infections and toxin exposure in particular can affect digestive and hormonal systems in ways that overlap with symptoms patients associate with BII. Accelerated recovery, the final piece of the SHARP approach, is about giving patients and their care team a structured, individualized way to track progress over time rather than treating recovery as a single event tied only to the day of surgery.
Patients who want to learn more about how this framework is applied can review the SHARP approach directly, and those preparing for surgery may also find the Pre and Post Surgery Essentials collection useful for supporting this preparation phase.
Buy Dr. Robert Whitfield's book about SHARP: https://drrobssolutions.com/products/sharp-by-dr-robert-whitfield
Frequently Asked Questions
Can Lyme disease cause breast implant illness symptoms? There is no established causal link showing that Lyme disease causes breast implant illness. What this conversation highlights is that Lyme disease and its related co-infections are one of several possible sources of chronic inflammation that some patients with implants are also carrying, which can make their overall symptom picture more complex to sort through.
How do doctors test for chronic Lyme disease? Testing typically starts with antibody-based panels looking at IgG and IgM markers, though ELISpot testing and PCR testing are also used by some practitioners. Each method has different strengths and limitations, so interpretation usually depends on correlating results with a patient's history and symptoms rather than relying on any single test alone.
What is a glutathione provocative challenge for mold testing? It is a testing approach some integrative practitioners use before running a mycotoxin panel, intended to help reveal a clearer picture of mold-related toxin burden. It is one tool among several and is typically interpreted alongside a patient's exposure history and other lab findings.
Do I need to test my whole house for mold? Not necessarily as a first step. Many practitioners recommend starting with air quality improvements, particularly in bedrooms and bathrooms, before pursuing a more extensive home investigation. For some patients, this step alone provides a meaningful improvement in how they feel.
Why are parasitic infections hard to diagnose? Many parasites are not consistently present in stool, so standard stool testing can miss an active infection. Diagnosis often depends on a detailed travel and symptom history combined with more specialized lab testing that is not always covered by insurance.
What is breast implant illness (BII)? Breast implant illness refers to a cluster of systemic symptoms some patients with breast implants report, including fatigue, joint pain, and cognitive changes. Dr. Whitfield describes it as a chronic inflammatory process in which the implant may play a role alongside other contributing factors, rather than a single, fully defined diagnosis with one identified cause.
How can I find out what might be contributing to my chronic inflammation? A comprehensive evaluation that reviews your health history, environmental exposures, and relevant lab testing is typically the starting point. Scheduling a discovery call is one way to begin that conversation with Dr. Whitfield's team.
Disclaimer: The content provided in this article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any changes to your health regimen, supplements, or treatment plan. Results discussed are not guaranteed and individual outcomes will vary.
Take the Next Step
Take a free health assessment now: https://www.drrobertwhitfield.com/sharp
Download your free inflammation support guide: https://www.drrobssolutions.com/products/free-inflammation-support-guide
Book a discovery call now: https://discovery.drrobertwhitfield.com/form
Check out Dr. Robert Whitfield's favorite supplements and labs: https://drrobssolutions.com/products/inflammation-support-bundle
Guest credit: Dr. Mark Su, Rootseek.com (drmarksue.com)